Ekaterina Besse

Ekaterina Besse is a Project Owner at Qubit Pharmaceuticals, a company that specializes in drug discovery and design using quantum physics to develop treatments for major diseases.1

Professional Background

Ekaterina Besse has an impressive background in entrepreneurship and technology:

• She is currently a Project Owner at Qubit Pharmaceuticals.23
• Previously, she co-founded and served as the Chief Product Officer (CPO) at QuantsUnited, a company that was later acquired by Synthetic Neural Labs Inc.2
• Before that, she was the co-founder and CEO of DreamUp Vision.2

Education and Expertise

Ekaterina holds a PhD in Theoretical Physics3, which likely contributes to her work in the quantum physics-based approach to drug discovery at Qubit Pharmaceuticals.

Current Role

At Qubit Pharmaceuticals, Ekaterina is part of a team that aims to bring "unparalleled accuracy and precision to drug discovery and design" by leveraging quantum physics to develop innovative treatments.1 The company, founded in 2020, employs about 60 people and focuses on tackling complex drug targets that were previously considered "undruggable".1

Ekaterina's role as a Project Owner likely involves overseeing specific drug discovery projects or initiatives within the company, utilizing her background in physics and her experience in entrepreneurship and product development.